Background
Uveal melanoma (UM) is a rare tumor of the eye which is biologically distinct from cutaneous melanoma (CM). Treatment options for patients with metastatic uveal melanoma (mUM) are limited as mUM tends to be resistant to commonly used treatments for cutaneous melanoma. Therefore, a better understanding of the biology of this tumors is needed in order to develop new treatment options. Therefore, we aimed to examine a multi-omics profile of UM as compared to CM.